LCTX Operating Cash Flow (Statement)

Lineage Cell Therapeutics, Inc. Common Stock · Operating Cash Flow (Statement)

LCTX logo

LCTX Operating Cash Flow (Statement)

Latest reported-$23.82M
LCTX TTM Cash from Operations (-$1.40M → -$23.82M)
High-resolution chart · PNG

LCTX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-23,815,999
-22,110,999
-18,919,000
-20,387,000
-22,558,000
-22,195,000
-23,092,000
-22,765,000
-22,015,000
-23,107,000
-28,566,000
-30,850,000
-31,293,000
-32,087,000
1,059,000
3,489,000
4,121,000
5,767,000
-23,561,000
-23,329,000
-23,328,000
-22,151,000
-19,753,000
-19,635,000
-22,231,000
-27,659,000
-31,947,000
-32,236,000
-32,125,000
-29,858,000
-30,882,000
-30,745,000
-31,094,000
-32,757,000
-30,517,000
-33,694,000
-34,928,000
-36,111,000
-42,326,000
-47,421,000
-50,067,000
-49,788,179
-44,544,000
-39,707,192
-36,754,951
-37,565,750
-38,854,200
-38,370,942
-36,178,623
-32,844,202
-29,508,613
-25,877,757
-24,470,078
-20,984,266
-19,679,518
-18,279,056
-16,865,689
-15,703,411
-13,593,916
-12,775,403
-11,178,909
-10,113,742
-7,732,884
-5,801,350
-5,260,306
-4,460,734
-4,259,938
-3,926,053
-2,787,276
-2,359,781
-1,604,245
-1,447,063
-1,281,466
-1,128,271
-1,239,980
-1,075,293
-1,159,751
-899,423
-1,262,219
-723,526
-1,146,390
-1,499,906
-1,414,148
-1,961,109
-1,482,588
-1,426,344
-1,536,696
-1,802,964
-1,089,541
-862,579
-654,144
-702,593
-1,698,631
-2,024,790
-2,129,155
-1,900,378
-2,541,670
-2,863,263
-3,209,834
-3,784,286
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.